Remgro Share Price JSE Resumes Uptrend Toward R200 on Strong Earnings Growth and Dividend
Remgro Limited reported robust interim earnings growth, helping its share price recover and resume its broader upward trend.
Quick overview
- Remgro Limited reported strong interim earnings growth for the six months ended December 31, 2025, with revenue rising to ZAR 27.1 billion.
- Net income increased significantly to ZAR 5.17 billion, and headline earnings climbed 38.8% to ZAR 5.1 billion, driven by improved contributions from key investee companies.
- The company declared an interim dividend of 173 cents per share, reflecting an 80% increase and strong cash generation.
- Following the release of robust earnings, Remgro's share price rebounded, indicating renewed investor confidence and potential for continued growth.
Remgro Limited reported robust interim earnings growth, helping its share price recover and resume its broader upward trend.
Strong Interim Financial Performance
Remgro Limited delivered solid results for the six months ended December 31, 2025, reflecting improved operational performance across its portfolio. Revenue increased to ZAR 27.1 billion, up from ZAR 26.4 billion a year earlier.
Net income rose significantly to ZAR 5.17 billion, compared to ZAR 3.66 billion previously. Headline earnings climbed 38.8% to ZAR 5.1 billion, highlighting strong underlying profitability. This performance was largely driven by improved contributions from key investee companies and a recovery in CIVH.
Earnings Per Share Show Solid Growth
Profitability gains were also reflected at the per-share level:
- Basic earnings per share (EPS): ZAR 9.30, up from ZAR 6.59
- Diluted EPS: ZAR 9.22, up from ZAR 6.53
The strong EPS growth underscores the company’s ability to translate operational improvements into shareholder value.
Dividend Reflects Strong Cash Generation
Remgro declared an interim dividend of 173 cents per share, representing an 80% increase compared to the prior period.
The sharp rise in dividends signals robust cash generation at the holding company level and confidence in the sustainability of earnings.
Share Price Rebounds After Pullback
The stock experienced a period of weakness in late February, declining around 11% amid broader market volatility.
However, following the release of strong earnings, shares rebounded and are now moving back toward recent highs. The recovery suggests renewed investor confidence and a continuation of the longer-term uptrend.
Outlook: Momentum Builds Toward Long-Term Highs
With improved earnings, strong cash flow, and recovering portfolio performance, Remgro appears to be regaining momentum.
If current trends persist, the stock could continue advancing toward its longer-term highs, supported by consistent earnings growth and disciplined capital allocation.
Market Response and Share Price Rallies
The upbeat earnings guidance and subsequent strong results translated directly into market enthusiasm. Remgro’s share price surged from R179 at the start of the week to R187, after finding support and rebounding off the 200 daily SMA. On a yearly basis, the stock is up 16.4%, reflecting both recovery from late-2024 declines and confidence in the group’s long-term trajectory.
REMJ Chart Monthly – Heading to 2015 Highs
On the monthly timeframe, the share price has rebounded convincingly from its 200-month SMA and now trades closer to the historic highs of 2015 around R200. This resilience underscores investors’ renewed belief in Remgro’s diversified portfolio and earnings potential.
- Headline Earnings: Increased 38.8% to R5.1 billion (2024: R3.7 billion).
- Headline Earnings Per Share (HEPS): Increased 38.5% to 931 cents.
- Interim Dividend: Raised 80% to 173 cents per share.
- Revenue: Group revenue rose 2.8% to R27.13 billion.
- Cash Flow: Solid cash generation at the centre, with sustainable dividends from investees rising 34% to R2.43 billion.
- Investee Performance: Significant contributions from Mediclinic Holdings (R485 million), Rainbow Chicken (R280 million), and Heineken Beverages (R166 million).
- CIVH Recovery: The CIVH-Vodacom transaction, which was completed in December 2025, contributed to a strong performance, including a special dividend of R2.66 billion.
- Operational Challenges: Despite the growth, the company cited exposure to geopolitical volatility, specifically through Mediclinic’s operations in the UAE.
Remgro remains focused on disciplined capital allocation and growing its portfolio, noting that the company is well-positioned for future growth despite a volatile macroeconomic environment
- Check out our free forex signals
- Follow the top economic events on FX Leaders economic calendar
- Trade better, discover more Forex Trading Strategies
- Open a FREE Trading Account
- Read our latest reviews on: Avatrade, Exness, HFM and XM
Related Articles
Sidebar rates
Related Posts
Save